Travere Therapeutics (TVTX) Intangibles (2012 - 2026)
Travere Therapeutics (TVTX) recorded Intangibles of $131.52 million in Q2 2026, up 24.5% from $105.61 million a year earlier and up 19.5% from the prior quarter.
Travere Therapeutics (TVTX) Intangibles (2012 - 2026) Analysis & Trends
At the end of FY2025, Travere Therapeutics reported Intangibles of $113.87 million, up 9.5% from FY2024.
- Annual Intangibles has a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
- Across earlier years, Intangibles came in at $103.97 million in FY2024 (-0.4%), $104.44 million in FY2023 (+7.6%), $97.07 million in FY2022 (-34.6%) and $148.44 million in FY2021 (-3.7%).
- The Q2 2026 figure is the highest quarterly Intangibles since Q2 2023.
- On a year-over-year basis, Intangibles has increased for six consecutive quarters, with growth averaging 5.6% over the last eight quarters.
- Peak year-over-year performance for Intangibles in the last five years was growth of 24.5% in Q2 2026, against a decline of 37.9% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $110.04 million (Q1 2026), $113.87 million (Q4 2025) and $109.44 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Travere Therapeutics | 4.88 Bn | 4.48 Bn | 167.41 Mn | 131.52 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 131.52 Mn |
| Mar 31, 2026 | 110.04 Mn |
| Dec 31, 2025 | 113.87 Mn |
| Sep 30, 2025 | 109.44 Mn |
| Jun 30, 2025 | 105.61 Mn |
| Mar 31, 2025 | 103.82 Mn |
| Dec 31, 2024 | 103.97 Mn |
| Sep 30, 2024 | 104.21 Mn |
| Jun 30, 2024 | 105.17 Mn |
| Mar 31, 2024 | 101.18 Mn |
| Dec 31, 2023 | 104.44 Mn |
| Sep 30, 2023 | 106.90 Mn |
| Jun 30, 2023 | 154.46 Mn |
| Mar 31, 2023 | 162.88 Mn |
| Dec 31, 2022 | 97.07 Mn |
| Sep 30, 2022 | 149.47 Mn |
| Jun 30, 2022 | 149.92 Mn |
| Mar 31, 2022 | 153.32 Mn |
| Dec 31, 2021 | 148.44 Mn |
| Sep 30, 2021 | 148.70 Mn |
Travere Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=TVTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();